Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Bluejay Diagnostics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 9 | +9 |
| Shares | 0 | 104.3K | +104.3K |
| Value | $0 | $267.0K | +$267.0K |
New holders (9)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 32,170 | $82.0K | 0.00% |
| Jane Street Group, LLC | 23,748 | $61.0K | 0.00% |
| Perkins Capital Management Inc | 22,500 | $58.0K | 0.04% |
| Two Sigma Securities, LLC | 15,806 | $40.0K | 0.01% |
| UBS Group AG | 5,014 | $13.0K | 0.00% |
| BlackRock Inc. | 4,346 | $11.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 227 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 500 | $1.00K | 0.00% |
| Wells Fargo & Company | 13 | $0 | 0.00% |
Sold out (0)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.